Vascarta Inc.
- Biotech or pharma, therapeutic R&D
Vascarta is a clinical stage pharmaceutical company that has developed a patented topical- transdermal delivery technology. We are able to harness the proven anti-inflammatory efficacy of curcumin through transdermal delivery which overcomes the limited bioavailability of oral dosing. Our pre-clinical animal data is compelling, leading to our clinical programs. In Sickle Cell Disease and Osteoarthritis initiated 1Q-2025 with expected completion by 4Q-2025.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}